MediFind found 53 doctor with experience in Acute Megakaryoblastic Leukemia near Saitama, 11. Of these, 49 are Experienced, 2 are Advanced, 1 are Distinguished and 1 are Elite.
Daisuke Tomizawa practices in Tokyo, Japan. Mr. Tomizawa is rated as an Elite expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Etsuro Ito practices in Tokyo, Japan. Ito is rated as a Distinguished expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, Down Syndrome, and Bone Marrow Transplant.
Akira Oka practices in Chuo, Japan. Oka is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Congenital Cytomegalovirus, Prognathism, Cytomegalic Inclusion Disease, and Alopecia Areata.
Hideki Mitomo practices in Tohoku, Japan. Mr. Mitomo is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Lambert-Eaton Syndrome, Germ Cell Tumor, Acute Megakaryoblastic Leukemia, Cardiac Tamponade, and Lung Transplant.
Toshiharu Tabata practices in Tohoku, Japan. Mr. Tabata is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Collapsed Lung, Lambert-Eaton Syndrome, Lung Cancer, and Solitary Fibrous Tumor.
Kyoko Inokura practices in Tohoku, Japan. Ms. Inokura is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Her top areas of expertise are Acute Megakaryoblastic Leukemia, Angioimmunoblastic T-cell Lymphoma, T-Cell Lymphoma, and Henoch-Schonlein Purpura.
Kenichi Yoshida practices in Tokyo, Japan. Mr. Yoshida is rated as an Advanced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Leukemia, Aplastic Anemia, Pancreaticoduodenectomy, and Bone Marrow Aspiration.
St Luke's International Hospital
Daisuke Hasegawa practices in Tokyo, Japan. Mr. Hasegawa is rated as an Advanced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Leukemoid Reaction, Down Syndrome, Leukemia, Endoscopy, and Vitrectomy.
Shinichi Makita practices in Tokyo, Japan. Mr. Makita is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant.
Naoyuki Uchida practices in Tokyo, Japan. Uchida is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.
Takahiro Fukuda practices in Tokyo, Japan. Mr. Fukuda is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Adult T-Cell Leukemia, Bone Marrow Transplant, and Bone Graft.
Tomohiko Taki practices in Mitaka, Japan. Taki is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Childhood Acute Myeloid Leukemia, Leukemia, Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL).
Fumio Bessho practices in Mitaka, Japan. Mr. Bessho is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Acute Megakaryoblastic Leukemia, Immune Thrombocytopenic Purpura (ITP), Purpura, and Langerhans Cell Histiocytosis.
Kunimasa Yan practices in Mitaka, Japan. Yan is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Nephrotic Syndrome, Diabetic Nephropathy, Minimal Change Disease, Joubert Syndrome, and Appendectomy.
Hirokazu Kanegane practices in Tokyo, Japan. Kanegane is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are X-Linked Lymphoproliferative Disease, Primary Immunodeficiency (PID), IPEX Syndrome, ZAP70-Related Severe Combined Immunodeficiency, and Bone Marrow Transplant.
Mitsuteru Hiwatari practices in Tokyo, Japan. Hiwatari is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Their top areas of expertise are Neuroblastoma, Acute Lymphoblastic Leukemia (ALL), Testicular Yolk Sac Tumor, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Transplant.
Tetsuro Ochi practices in Tokyo, Japan. Mr. Ochi is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Sideroblastic Anemia, Familial Wilms Tumor 2, Large-Cell Immunoblastic Lymphoma, Acute Megakaryoblastic Leukemia, and Bone Marrow Transplant.
Yo Saito practices in Tokyo, Japan. Ms. Saito is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. Her top areas of expertise are Acute Megakaryoblastic Leukemia, Follicular Lymphoma, Plasmacytoma, and Non-Hodgkin Lymphoma.
Ken Ishiyama practices in Tokyo, Japan. Mr. Ishiyama is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Anemia, and Bone Marrow Transplant.
Kentaro Ohki practices in Tokyo, Japan. Mr. Ohki is rated as an Experienced expert by MediFind in the treatment of Acute Megakaryoblastic Leukemia. His top areas of expertise are Childhood Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia (ALL), Leukemia, Leukemoid Reaction, and Bone Marrow Transplant.
Last Updated: 01/09/2026


